Ovalbumin content of 2010-2011 influenza vaccines

According to the US Food and Drug Administration (FDA), as of January 12, 2011, individual manufacturers have produced between 18 and 145 lots of influenza vaccine. The lowest coefficient of variation was seen with FluMist at 9%. Because only 1 lot of Fluarix was measured, there are no data on varia...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of allergy and clinical immunology 2011-06, Vol.127 (6), p.1629-1632
Hauptverfasser:	McKinney, Kristi K., MD, Webb, Luke, MD, Petersen, Maureen, MD, Nelson, Michael, MD, Laubach, Susan, MD
Format:	Artikel
Sprache:	eng
Schlagworte:	Allergy and Immunology Animals Chickens Egg Hypersensitivity - immunology FDA approval Humans Immunization Influenza Influenza Vaccines - adverse effects Influenza Vaccines - analysis Influenza Vaccines - immunology Laboratories Ovalbumin - adverse effects Ovalbumin - analysis Ovalbumin - immunology Seasons Time Factors Vaccines
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	According to the US Food and Drug Administration (FDA), as of January 12, 2011, individual manufacturers have produced between 18 and 145 lots of influenza vaccine. The lowest coefficient of variation was seen with FluMist at 9%. Because only 1 lot of Fluarix was measured, there are no data on variability this season for Fluarix.
ISSN:	0091-6749 1097-6825
DOI:	10.1016/j.jaci.2011.02.003